The Clinical Unit for Research Innovation and Trials (CUReIT) supports observational and interventional clinical studies across the breadth of the development spectrum. In the context of world-renowned disease state and cutaneous immunology expertise, we offer a unique opportunity for translational research that includes clinical outcome measure development, study consulting and trials support from proof-of-concept through registrational / Phase III studies and post-marketing registry and phase IV endeavors. We are able to utilize central Institutional Review Board (IRB) for a subset of industry-sponsored studies and master agreements are often in place to facilitate study startup. We have emphasized investigator-initiated studies to support the academic work and expertise of our faculty and allow innovation within the field.
Please contact our CUReIT team, for any study inquiries BWHDermClinicalTrials@bwh.harvard.edu
